DCF — MEDICAL UNIVERSITY OF SOUTH CAROLINA
Enterprise Value: $-1.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.2B
Enterprise Value
$-450.5M
PV of Cash Flows
$-768.7M
PV of Terminal Value
$-1.2B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.7B | $-40.6M | -2.0% | $-154.4M | $-140.4M |
| Year 2 | $2.8B | $-14.2M | -1.0% | $-131.4M | $-108.6M |
| Year 3 | $2.9B | $13.9M | 0.0% | $-106.8M | $-80.2M |
| Year 4 | $2.9B | $29.0M | 1.0% | $-95.3M | $-65.1M |
| Year 5 | $3.0B | $37.5M | 1.0% | $-90.6M | $-56.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.6B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.020113600095658216
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5